Regis Healthcare Limited

ASX:REG Stock Report

Market Cap: AU$1.8b

Regis Healthcare Management

Management criteria checks 4/4

Regis Healthcare's CEO is Linda Mellors, appointed in Sep 2019, has a tenure of 6.67 years. total yearly compensation is A$1.91M, comprised of 43.4% salary and 56.6% bonuses, including company stock and options. directly owns 0.16% of the company’s shares, worth A$2.91M. The average tenure of the management team and the board of directors is 5 years and 6.7 years respectively.

Key information

Linda Mellors

Chief executive officer

AU$1.9m

Total compensation

CEO salary percentage43.36%
CEO tenure6.7yrs
CEO ownership0.2%
Management average tenure5yrs
Board average tenure6.7yrs

Recent management updates

Recent updates

Narrative Update Mar 11

REG: RAD Retention And M&A Pipeline Will Support Future Earnings Upside

Analysts now see a slightly different outlook for Regis Healthcare, with the updated price target moving in line with minor tweaks to revenue growth, profit margin assumptions and future P/E expectations. This results in a refined valuation around A$8.32 per share.
Narrative Update Feb 25

REG: RAD Retention And Acquisitions Will Support Future Earnings Upside

Analysts have raised their fair value estimate for Regis Healthcare to A$8.32 from A$7.98, reflecting updated assumptions on revenue growth, profit margins, the discount rate and future P/E expectations. What's in the News Regis Healthcare states it will look for acquisition opportunities, supported by what it describes as substantial operating cash flow from its core business and a strong balance sheet with undrawn debt capacity (Key Developments).
Analysis Article Oct 15

Regis Healthcare Limited (ASX:REG) May Have Run Too Fast Too Soon With Recent 25% Price Plummet

Regis Healthcare Limited ( ASX:REG ) shareholders won't be pleased to see that the share price has had a very rough...
Narrative Update Sep 23

Australia Aged Care Demand Will Fuel Residential Expansion

The consensus analyst price target for Regis Healthcare has been revised down from A$8.61 to A$7.98, primarily reflecting weaker profitability as net profit margin declined and valuation multiples edged higher. What's in the News Regis Healthcare announced a fully franked ordinary dividend of AUD 0.0813 per share for the six months ended June 30, 2025.
Narrative Update Aug 27

Australia's Aged Care Reforms Will Reshape Service Landscapes

Despite a slight reduction in consensus revenue growth forecasts, the analyst price target for Regis Healthcare has increased from A$8.19 to A$8.61, likely reflecting stability in profit margins and overall valuation confidence. What's in the News Regis Healthcare announced a fully franked ordinary dividend of AUD 0.0813 per share for the six months ended June 30, 2025.
User avatar
New Narrative Aug 08

Australia's Aged Care Reforms Will Reshape Service Landscapes

Strong demographic trends and supportive government reforms are driving higher occupancy, pricing power, and revenue stability for Regis Healthcare.
Analysis Article Jul 31

When Should You Buy Regis Healthcare Limited (ASX:REG)?

While Regis Healthcare Limited ( ASX:REG ) might not have the largest market cap around , it received a lot of...
Analysis Article Jul 07

An Intrinsic Calculation For Regis Healthcare Limited (ASX:REG) Suggests It's 28% Undervalued

Key Insights Regis Healthcare's estimated fair value is AU$10.45 based on 2 Stage Free Cash Flow to Equity Regis...
Analysis Article Apr 07

Take Care Before Diving Into The Deep End On Regis Healthcare Limited (ASX:REG)

There wouldn't be many who think Regis Healthcare Limited's ( ASX:REG ) price-to-sales (or "P/S") ratio of 1.8x is...
Analysis Article Dec 20

Investor Optimism Abounds Regis Healthcare Limited (ASX:REG) But Growth Is Lacking

There wouldn't be many who think Regis Healthcare Limited's ( ASX:REG ) price-to-sales (or "P/S") ratio of 1.8x is...
Analysis Article Sep 12

Regis Healthcare Limited's (ASX:REG) P/S Is Still On The Mark Following 31% Share Price Bounce

The Regis Healthcare Limited ( ASX:REG ) share price has done very well over the last month, posting an excellent gain...
Analysis Article May 02

Is There An Opportunity With Regis Healthcare Limited's (ASX:REG) 38% Undervaluation?

Key Insights Regis Healthcare's estimated fair value is AU$6.05 based on 2 Stage Free Cash Flow to Equity Regis...
Analysis Article Mar 21

At AU$3.94, Is It Time To Put Regis Healthcare Limited (ASX:REG) On Your Watch List?

Regis Healthcare Limited ( ASX:REG ), might not be a large cap stock, but it led the ASX gainers with a relatively...
Analysis Article Feb 28

Regis Healthcare (ASX:REG) Has Announced A Dividend Of A$0.0628

Regis Healthcare Limited's ( ASX:REG ) investors are due to receive a payment of A$0.0628 per share on 11th of April...
Analysis Article Oct 18

Regis Healthcare Limited's (ASX:REG) CEO Compensation Looks Acceptable To Us And Here's Why

Key Insights Regis Healthcare will host its Annual General Meeting on 23rd of October CEO Linda Mellors' total...
Analysis Article Aug 29

Regis Healthcare (ASX:REG) Is Paying Out A Larger Dividend Than Last Year

Regis Healthcare Limited ( ASX:REG ) has announced that it will be increasing its dividend from last year's comparable...
Analysis Article Mar 01

Regis Healthcare (ASX:REG) Is Paying Out Less In Dividends Than Last Year

Regis Healthcare Limited ( ASX:REG ) has announced it will be reducing its dividend payable on the 14th of April to...
Analysis Article Oct 27

Is Regis Healthcare (ASX:REG) Using Debt Sensibly?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article Aug 26

Regis Healthcare's (ASX:REG) Shareholders Will Receive A Smaller Dividend Than Last Year

Regis Healthcare Limited's ( ASX:REG ) dividend is being reduced from last year's payment covering the same period to...
Analysis Article Feb 25

Regis Healthcare Limited's (ASX:REG) Intrinsic Value Is Potentially 34% Above Its Share Price

Does the February share price for Regis Healthcare Limited ( ASX:REG ) reflect what it's really worth? Today, we will...

CEO Compensation Analysis

How has Linda Mellors's remuneration changed compared to Regis Healthcare's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2025n/an/a

AU$38m

Sep 30 2025n/an/a

AU$43m

Jun 30 2025AU$2mAU$827k

AU$49m

Mar 31 2025n/an/a

AU$32m

Dec 31 2024n/an/a

AU$15m

Sep 30 2024n/an/a

-AU$3m

Jun 30 2024AU$2mAU$789k

-AU$21m

Mar 31 2024n/an/a

-AU$18m

Dec 31 2023n/an/a

-AU$15m

Sep 30 2023n/an/a

-AU$22m

Jun 30 2023AU$1mAU$755k

-AU$28m

Mar 31 2023n/an/a

-AU$45m

Dec 31 2022n/an/a

-AU$61m

Sep 30 2022n/an/a

-AU$50m

Jun 30 2022AU$952kAU$711k

-AU$39m

Mar 31 2022n/an/a

-AU$16m

Dec 31 2021n/an/a

AU$8m

Sep 30 2021n/an/a

AU$14m

Jun 30 2021AU$767kAU$698k

AU$20m

Mar 31 2021n/an/a

AU$8m

Dec 31 2020n/an/a

-AU$4m

Sep 30 2020n/an/a

-AU$2m

Jun 30 2020AU$729kAU$643k

-AU$716k

Compensation vs Market: Linda's total compensation ($USD1.38M) is about average for companies of similar size in the Australian market ($USD1.58M).

Compensation vs Earnings: Linda's compensation has been consistent with company performance over the past year.


CEO

Linda Mellors

6.7yrs
Tenure
AU$1,906,843
Compensation

Dr. Linda Jane Mellors, B.A., B.Sc. (Hons), Ph.D. (Med) GAICD, Grad Cert HSM, has been Chief Executive Officer of Regis Healthcare Limited since September 4, 2019 and serves as its Managing Director and Di...


Leadership Team

NamePositionTenureCompensationOwnership
Linda Mellors
CEO, MD & Director6.7yrsAU$1.91m0.16%
A$ 2.9m
Rick Rostolis
Chief Financial Officer6.2yrsAU$1.35m0.044%
A$ 812.8k
Jenn Armor
Chief Operating Officerless than a yearno datano data
Imtiaz Bhayat
Chief Information Officer5.6yrsno datano data
Malcolm Ross
General Counsel & Company Secretary4.5yrsno datano data
Jodie Haydon
Chief People Officer2.3yrsno datano data
5.0yrs
Average Tenure

Experienced Management: REG's management team is seasoned and experienced (5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Linda Mellors
CEO, MD & Director6.7yrsAU$1.91m0.16%
A$ 2.9m
Graham Hodges
Independent Non-Executive Chairman8.8yrsAU$290.00k0.044%
A$ 800.0k
Christine Bennett
Independent Non-Executive Director8.2yrsAU$200.00k0.027%
A$ 500.0k
Ian Roberts
Non-Executive Director11.6yrsAU$180.00k27.1%
A$ 496.5m
Carmel Monaghan
Independent Non-Executive Directorless than a yearno data0.00073%
A$ 13.4k
Jodie Leonard
Independent Non-Executive Director2.5yrsAU$191.00k0.011%
A$ 204.1k
Sally Freeman
Independent Non-Executive Director4.3yrsAU$200.00k0.029%
A$ 528.8k
6.7yrs
Average Tenure
63.5yo
Average Age

Experienced Board: REG's board of directors are considered experienced (6.7 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/14 15:51
End of Day Share Price 2026/05/14 00:00
Earnings2025/12/31
Annual Earnings2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Regis Healthcare Limited is covered by 15 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
William DunlopBofA Global Research
David StantonCLSA
David LowDeutsche Bank